While WS1 and AD are distinct diseases, they share important molecular mechanisms, including disruptions in ER homeostasis, alterations in calcium regulation, and increased ER stress, all of which contribute to neurodegeneration in both conditions. This evidence concerns the gene PAX3 and Alzheimer disease.